This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 2.99% to $1.30 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
This was the stock's fourth consecutive day of losses.
Ocugen Inc. closed 52.29% below its 52-week high of $2.73, which the company achieved on March 17th.
Trading volume (5.5 M) remained 3.9 million below its 50-day average volume of 9.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-19-26 1727ET

OCGN

IBBQ

LABU

SBIO

Ocugen Inc. (OCGN) shares fell 2.99% to $1.30 on Tuesday, marking the fourth consecutive day of losses. The stock is now 52.29% below its 52-week high of $2.73 reached on March 17. The broader market also declined, with the S&P 500 down 0.67% and the Dow Jones down 0.65%. Trading volume was 5.5 million, below the 50-day average of 9.4 million.

MarketWatch Automated

Ocugen

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

S&P 500

Dow Jones Industrial Average

Ocugen Inc. Stock Falls Tuesday, Underperforms Market